BHC:NYSE, Bausch Health Companies Inc.
BHC stock overview
Bausch Health Companies Inc. (BHC:NYSE) closed at $6.44 on October 23, 2026,
down 0.77% on the day.
The stock trades 19.5% below its 52-week high of $8.00
and 48.7% above its 52-week low of $4.33.
Over the past year, it gained 3.9%.
Bausch Health Companies Inc. is part of the Health Care sector (Major Pharmaceuticals).
Key figures
- Price
- $6.44
- Day change
- -0.77%
- Volume
- 2,400,625
- Average volume
- 3,238,034
- Market cap
- 2B+
- 52-week range
- $4.33 – $8.00
- 50-day average
- $6.17
- 200-day average
- $5.71
Price action over the past year
In 252 trading sessions since October 23, 2025, BHC closed higher on 121 days (48%).
Its best day was July 30, 2026 (+28.85%) and its worst was January 23, 2026 (-10.05%).
The stock moved 10% or more in a single session 5 times.
It opened at least 5% above the previous day's high 1 time.
Recent signals
BHC news
-
Oct 20, 2026:
Bausch Health's Third Quarter Tests Whether Its Guidance Raise Can Survive A Promised Slowdown
-
Oct 19, 2026:
Bausch Health Canada Announces Expanded Public Reimbursement for (Pr)OKEDI® (Risperidone for Extended-Release Injectable Suspension) Across Canada for the Treatment of Schizophrenia
-
Oct 12, 2026:
Six-Month Pilot Study Demonstrates Improved Guideline Adherence Following Implementation of Standardized Cirrhosis Clinical Pathway
-
Oct 12, 2026:
Bausch + Lomb and Bausch Health Announce Appointment of Thomas J. Appio as Interim Bausch + Lomb CEO, Expect to Raise Full-Year 2026 Guidance
-
Oct 6, 2026:
Bausch Health to Announce Third Quarter 2026 Results on October 28, 2026
-
Oct 5, 2026:
The Zacks Analyst Blog Highlights Abbott, Corcept, Precigen and Bausch Health Companies
-
Oct 2, 2026:
4 Low-Beta Healthcare Stocks to Buy Amid Fears of Another Rate Hike
-
Sep 30, 2026:
Consumer Confidence Falls Amid Ongoing Geopolitical Tensions: 4 Picks
About Bausch Health Companies Inc.
Valeant Pharmaceuticals International Inc is a specialty pharmaceutical and medical device company which develops, manufactures, and markets a range of generic and branded generic pharmaceuticals, over-the-counter products and medical devices.
Similar stocks
Find more stocks like BHC with the
Spikes,
Gaps,
Breakouts and
Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.